赛升药业：子公司药品生产许可证生产负责人变更

Core Viewpoint - The announcement indicates that Junyuan Pharmaceutical, a subsidiary of Saiseng Pharmaceutical, has received a drug production license from the Liaoning Provincial Drug Administration, which is expected to maintain stable production capacity without significant impact on the company's performance [1] Group 1 - Junyuan Pharmaceutical has been granted a drug production license with the license number Liao 20210198, valid until April 7, 2026 [1] - The production manager has been changed from Li Li to Liu Huifeng, while other details remain unchanged [1] - The change is beneficial for maintaining stable production capabilities and ensuring normal business operations [1]